HOME >> MEDICINE >> NEWS
NIH awards funding to biotech firm for heart disease

ugment conventional therapies such as artery bypass grafting and angioplasty. Ateriocyte's unique combination of blood cell types has shown encouraging results in animal studies.

Laughlin is director of the Allogeneic Transplant Program at University Hospitals of Cleveland and associate professor of medicine and pathology at Case Western Reserve University. Pompili is director of Interventional Cardiology at University Hospitals of Cleveland and associate professor of medicine and director of coronary care services at Case Western Reserve University. The company is based on technologies developed by the founders and Steven Haynesworth, associate dean of the College of Arts and Sciences at Case. Don Brown, a former executive of Viacell and Schering-Plough, is the company's chief executive officer. The university invested $250,000 in Arteriocyte through its Case Technology Ventures fund.

The grant is part of the NIH's Small Business Technology Transfer Award program, which is designed to help the transfer of innovative technologies from an academic setting to the commercial sector and rapidly translate research discoveries made in the laboratory into therapy for patients.

Blocked or damaged blood vessels are a major cause of illness and death around the world. Atherosclerosis, for example, can lead to congestive heart failure and heart attacks. About 5 million people in the U. S. have heart failure and the number is growing. Each year, another 550,000 people are diagnosed for the first time. It contributes to or causes about 300,000 deaths each year. About 1 percent of the U.S. population over the age of 65 is diagnosed with congestive heart failure each year. Existing therapies include drugs, gene therapy, and vascular interventions for relief of arterial obstructions. In 2003, approximately 750,000 coronary artery bypass graft (CABG) surgeries were performed worldwide and approximately 1.8 million balloon angioplasty procedures were perfor
'"/>

Contact: George Stamatis
George.Stamatis@case.edu
216-368-3635
Case Western Reserve University
25-Apr-2005


Page: 1 2 3

Related medicine news :

1. University hospitals wins multiple national IT awards for electronic patient data bank
2. CIRM awards $3.79 million to Burnham Institute
3. The Burroughs Wellcome Fund awards $8 million to infectious disease investigators
4. Gerontological Society of America awards new Hartford Doctoral Fellowships
5. AACR awards minority and other underrepresented scientists
6. FNSNA awards $25,000 grant to Rutgers College of Nursing
7. International and American Associations for Dental Research present awards and fellowships
8. JDRF awards Emory $2.5 million to develop islet transplant technology
9. NIH awards $1 million to Temple University Hospital for neurological treatment studies
10. NHLBI awards 12 Womens Health Initiative contracts
11. The Gerontological Society of America awards new Hartford Doctoral Fellowships

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NIH awards funding biotech firm for heart disease

(Date:11/27/2014)... 27, 2014 According to a recent ... looking to break into the surgical robotics market ... other than the MIS field dominated by Intuitive. These ... U.S. surgical robotics market by 2020. , “The ... Kamran Zamanian, CEO and President of iData. “System sales ...
(Date:11/27/2014)... PITTSBURGH, PA (PRWEB) November 27, 2014 ... suffer from an embarrassing fact of life, and she ... musty a few minutes later, I decided that there ... longer periods," she said. , Easy to use and ... maintains freshness in a woman’s private areas throughout the ...
(Date:11/27/2014)... Dennis Thompson HealthDay Reporter ... Ebola vaccine appears to be safe and produces an immune ... according to early clinical trial results reported by the U.S. ... I clinical trial for the vaccine paves the way for ... and Sierra Leone as early as January, said Dr. Anthony ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 Now that ... season has officially launched, Emassagechair.com has announced ... Monday Discount Event. , Negotiating on behalf of ... top massage chair brands, Emassagechair.com has generated significant buzz ... deals and biggest discounts yet. , Shoppers are excited ...
(Date:11/27/2014)... Washington, DC (PRWEB) November 27, 2014 “LAB.C” ... Report, which features the latest and coolest technology products available ... NewsWatch, conducted the product review and shared with ... cable for iOS and Android devices. , Consumers love portability ... LAB.C. Their Cable Case for the iPhone5 and 5S ...
Breaking Medicine News(10 mins):Health News:U.S. Robotic Surgery Market Set to Diversify and Grow: Intuitive Surgical’s ‘da Vinci’ Robot Revenues to Increasingly Rely On Procedures and Services 2Health News:Early Trial Promising for Ebola Vaccine 2Health News:Early Trial Promising for Ebola Vaccine 3Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 2Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 3Health News:Emassagechair.com is Excited to Announce Their Biggest Discount Event of the Year, Starting the Day After Thanksgiving and Lasting Through The Holiday Weekend. 4Health News:Top Mobile Friendly Accessories were Featured on NewsWatch Television on October 30, 2014 2
(Date:11/27/2014)... Ireland , November 27, 2014 ... Investigational New Drug (IND) Application with the U.S. Food ... in Hovione,s strategy of developing improved drug delivery options ... for minocycline gel, a novel formulation using a new ... one of the most widely prescribed oral antibiotics for ...
(Date:11/26/2014)... 26, 2014  Thoratec Corporation (NASDAQ: THOR ... therapies to save, support and restore failing hearts, said ... conferences. On Tuesday, December 2, the company ... Jaffray Healthcare Conference.  D. Keith Grossman , President ... the company beginning at 11:30 a.m., Eastern Standard Time ...
(Date:11/26/2014)... SAN DIEGO , Nov. 26, 2014  Aethlon ... into a definitive agreement to raise approximately $3.3 million ... is being made by one institutional healthcare focused investor. Each ... one-fifth of a common share purchase warrant. Each whole ... at a price of $0.30 for a period of ...
Breaking Medicine Technology:Hovione Files its First Investigational New Drug Application With the FDA 2Thoratec Announces Presentations At Investor Conferences For December 2014 2Aethlon Medical Announces $3.3 Million Equity Investment 2Aethlon Medical Announces $3.3 Million Equity Investment 3
Cached News: